ÍøºìºÚÁÏ

Skip to main content

Clinical trials

  • ARISE II

    The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.

    Investigator
    Thomas M Beaver
    Ages
    18 Years - N/A
    Sexes
    All
  • URIPRENE

    A prospective, multi-center, non-randomized trial to demonstrate safety and device performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent.

    Investigator
    Vincent G Bird
    Ages
    21 Years - 80 Years
    Sexes
    All
  • DJUS Registry

    A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents

    Investigator
    Vincent G Bird
    Ages
    N/A - N/A
    Sexes
    All